Primary Pulmonary Meningioma Mimicking Lung Metastases by Tolay, Sameer, MD et al.
Lehigh Valley Health Network
LVHN Scholarly Works
Department of Medicine
Primary Pulmonary Meningioma Mimicking Lung
Metastases
Sameer Tolay MD
Lehigh Valley Health Network, sameer.tolay@lvhn.org
Brian J. Patson MD
Lehigh Valley Health Network, brian_j.patson@lvhn.org
Sherry Li MD
sherry_q.li@lvhn.org
Follow this and additional works at: https://scholarlyworks.lvhn.org/medicine
Part of the Medical Sciences Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Tolay, S. Patson, B. J., Li, S. Q. (2016,Sept). Primary Pulmonary Meningioma Mimicking Lung Metastases. Poster Presented at:
Pennsylvania Society of Hematology and Oncology, PSOH, Harrisburg, PA.
Lehigh Valley Health Network Allentown, Pennsylvania
Sameer Tolay, MD1, Brian J. Patson, MD1, Sherry Q. Li, MD2
1Hematology and Medical Oncology, 2Pathology, Health Network Laboratories
Primary Pulmonary Meningioma Mimicking Lung Cancer
© 2016 Lehigh Valley Health Network
CASE
•  A 67 year old never-smoker female presented with lower 
extremity edema.
•  Computerized tomography (CT) scan of chest, abdomen 
and pelvis showed an incidental finding of 1.4 cm well 
circumscribed non calcified left lower lobe pulmonary 
nodule with numerous tiny bilateral non calcified nodules.
•  18-F fluorodeoxyglucose positron emission tomography 
(FDG-PET) showed mild uptake (SUV 1.5) in the posterior 
left lower lobe pulmonary nodule.
•  No hypermetabolic mediastinal or hilar adenopathy seen.
•  Patient underwent left lower lobectomy with mediastinal 
lymph node dissection.
DIAGNOSIS
Patient underwent gadolinium enhanced 
magnetic resonance imaging (MRI) of the brain 
and spinal cord with no evidence of primary 
meningioma.
FINAL DIAGNOSIS
Benign ( Grade 1), Primary Pulmonary Meningioma
PATHOLOGY
Primary Pulmonary Meningioma -
A Very Rare Tumor
Epidemiology - Extra-
cranial/spinal meningioma is 
rare and usually involves 
head and neck region. 
Primary pulmonary menin-
gioma is even rarer with 
only 40 cases reported to 
date.
Clinical Behavior - These 
tumors are mostly detected 
incidentally and in contrast 
with the meningioma of the 
central nervous system, 
rarely cause any compressive 
symptoms.
Differentials - Primary and 
metastatic spindle and clear 
cell tumors of lung, pulmon-
ary metastases and solitary 
fibrous tumor of the pleura. 
Pathologic Behavior -
These are mostly benign in 
nature with an exception of 
3 cases, which were 
deemed malignant based 
on high mitotic activity, 
necrosis, lymph node or 
distant metastases. The 
histologic origin of these 
tumors is uncertain and 
pluripotent sub-pleural 
mesenchymal cells 
remains a possibility. 
Prognosis & 
Management -
Benign lesions: Excellent 
prognosis. Atypical lesions-
not much known. Surgical 
resection is the mainstay of 
treatment. Frozen section 
important to ensure clear 
margins.
CT scan showing left lower lobe lesion. Fused PET/CT showing mild avidity.
Pulmonary Meningioma low power 
(10x) with surrounding lung.
Low power view of Psammoma 
body within meningioma.
Psammoma bodes are concentric lamellated calcified 
structures most commonly seen in meningiomas, papillary 
carcinoma of thyroid and serous ovarian cystadenocarcinoma 
and represent infarction and calcification within a tumor. 
Low power view of positive staining pattern with EMA and 
Vimentin.
Gross/Morphology Immunohistochemistry
•  Numerous minute meningothelial-like nodules ranging from 0.4-1cm 
dispersed throughout the left lower lobe
•  The sections showed a spindle cell neoplasm with psammoma 
bodies without necrosis and cytologic atypia
•  All sampled lymph nodes were benign and surgical margins were 
clear of the disease process 
•  Positive for vimentin and epithelial membrane antigen (EMA)
•  Weakly positive for estrogen receptor (ER) 
•  Negative for cytokeratin AE1/AE3, PAX-8, S-100 protein, CD117, OCT-
2, glial fibrillary acidic protein (GFAP), desmin and smooth muscle actin 
(SMA)
•  Ki-67 stained less than 5% of tumor cells
